Chapter 6B Quiz

Comorbidity II

5 clinical cases · 17 questions

Each case presents a clinical scenario followed by board-style questions. Select your answer and submit to see the rationale.

Daisy, Age 8

Daisy is an 8-year-old girl with ADHD-Combined Presentation, well controlled on methylphenidate ER 36 mg for two years. Her mother brings her in because the school has called four times this month about explosive outbursts: throwing materials, screaming at a teacher, and shoving a classmate. Each episode was triggered by minor frustrations such as being told to wait her turn. Between outbursts, her mother describes Daisy as persistently irritable, angry, and difficult to be around. When the clinician asks what Daisy looks like on a good day, her mother says, "I can't remember the last one." This pattern has been present for over 14 months across home, school, and aftercare. Daisy has no history of discrete manic or hypomanic episodes.
Q1. The clinician is deciding whether Daisy's irritability represents ADHD emotional dysregulation or a comorbid diagnosis. Which of the following features most strongly supports adding a Disruptive Mood Dysregulation Disorder (DMDD) diagnosis?
Q2. Daisy also meets criteria for oppositional defiant disorder (ODD). The clinician is deciding which diagnosis to assign. Based on the DSM-5 hierarchical rules, which of the following is most appropriate?
Q3. Following the treatment algorithm for comorbid ADHD and DMDD, which of the following is the most appropriate first step?
Q4. Daisy's stimulant is optimized, but severe irritability persists. The clinician adds citalopram. At 8 weeks, outburst frequency has decreased from twelve per month to four, and her mother reports the first "okay days" in over a year. Which of the following best describes this response pattern?

Joaquin, Age 13

Joaquin is a 13-year-old boy referred for suspected ADHD. Over the past 18 months, his grades have dropped from As to Cs. He cannot complete homework, loses track of classroom instructions, and appears "spacey" during tests. A previous provider started atomoxetine 40 mg with minimal improvement and is considering switching to a stimulant. During the intake, Joaquin's mother mentions that he has started erasing and rewriting the same sentences repeatedly, sometimes five or six times, and asks whether homework answers are "right" despite clear evidence they are correct. His checking provides only seconds of relief before the urge returns. His mother confirms the concentration problems developed only after the checking behaviors started.
Q5. Before switching to a stimulant, the clinician considers the temporal pattern: Joaquin's concentration problems developed only after the checking behaviors started. This pattern is most consistent with which clinical model?
Q6. The clinician confirms OCD as the primary diagnosis. Joaquin is already taking atomoxetine, and the clinician considers adding fluoxetine for OCD. Which of the following is the most important safety concern with this combination?
Q7. The clinician selects escitalopram instead and initiates CBT with Exposure and Response Prevention (ERP). After 12 weeks of OCD treatment, Joaquin's obsessive symptoms have decreased substantially and his grades have returned to Bs. Residual mild inattention persists but does not cause functional impairment. Which of the following is the most appropriate next step regarding his atomoxetine?

Noor, Age 7

Noor is a 7-year-old boy in kinship foster care with a documented history of physical abuse and neglect. His caregiver reports severe hyperactivity, difficulty following instructions, exaggerated startle to unexpected sounds, and nightly nightmares. He was diagnosed with ADHD at age 5, and a previous provider prescribed methylphenidate, which was discontinued after two weeks because the caregiver reported worsening nightmares and startle responses. His therapist has attempted trauma-focused CBT (TF-CBT) but reports that Noor cannot sustain attention through the narrative exposure components, dissociates during emotional content, and cannot retain session-to-session material. His hyperactivity and impulsivity were documented before the abuse began.
Q8. The clinician is considering restarting ADHD pharmacotherapy. Given Noor's comorbid PTSD and hyperarousal, which medication class is the most appropriate first-line choice?
Q9. After 6 months on guanfacine XR, Noor's TF-CBT is progressing well and his PTSD symptoms have improved substantially. His ADHD symptoms remain well controlled. His caregiver asks whether guanfacine is still needed now that the trauma work is going better. Which of the following is the most appropriate response?
Q10. During the evaluation, the clinician learns that Noor's biological mother has active substance use disorder and has been requesting unsupervised visits. The caseworker is considering reunification. Given this context, which treatment consideration is most important?

Hugo, Age 10

Hugo is a 10-year-old boy with ADHD-Combined Presentation on methylphenidate ER 27 mg for eight months. His inattention at school has improved. His mother reports he takes over an hour to fall asleep most nights, wakes frequently, and complains of uncomfortable leg sensations that he describes as "creepy-crawlies" that only improve when he walks around. His mother attributes the insomnia to his ADHD medication. When asked, she says the sleep problems existed before starting methylphenidate but have worsened slightly since.
Q11. Before attributing Hugo's insomnia to his stimulant medication, which of the following is the most important clinical consideration?
Q12. The clinician orders a serum ferritin for Hugo's restless legs symptoms. The result is 38 ng/mL. His pediatrician notes this is within the normal pediatric reference range and suggests no intervention is needed. Which of the following is the most appropriate response?
Q13. The clinician starts melatonin 3 mg at bedtime for Hugo's persistent sleep onset delay. At 4 weeks, his mother reports minimal improvement. Hugo takes the melatonin immediately before lights-out at 9 PM, but his natural sleep onset remains around 10:30 PM. Which adjustment is most likely to improve response?
Q14. Hugo's mother asks when a sleep study should be considered. Which of the following is the strongest indication for polysomnography referral?

Simone, Age 11

Simone is an 11-year-old girl with ADHD-Predominantly Inattentive Presentation on atomoxetine 40 mg for one year. She was diagnosed with OCD six months ago after developing contamination fears and handwashing rituals. Her psychiatrist started fluoxetine 20 mg for OCD three months ago. At today's visit, Simone's mother reports that her pulse rate has increased, she has become more irritable, and she "isn't herself." The OCD symptoms have improved moderately on fluoxetine.
Q15. Given the medication combination Simone is taking, which of the following is the most likely explanation for her new symptoms?
Q16. The clinician decides to address the drug interaction. Which of the following is the most appropriate management strategy?
Q17. After resolving the drug interaction, Simone's OCD is stable on escitalopram and her ADHD is well-managed on atomoxetine. Her mother asks whether atomoxetine carries any risk of worsening Simone's OCD. Which of the following is the most accurate response?